CLOVER HEALTH INVESTMENTS, CORP. /DE 8-K

What Happened

• Clover Health Investments, Corp. announced its financial results for the fourth quarter and full year ended December 31, 2025 in a press release dated February 26, 2026. The company furnished that press release as Exhibit 99.1 to the Form 8-K filed the same day. The Form 8-K was signed by Peter Kuipers, Chief Financial Officer, on February 26, 2026.

Key Details

• Item reported: 2.02 — Results of Operations and Financial Condition (Q4 and year ended Dec. 31, 2025).
• Press release containing the results is furnished as Exhibit 99.1 to the Form 8-K (filed Feb 26, 2026).
• Exhibit 104: Cover Page Interactive Data File (Inline XBRL) was included with the filing.
• The report was signed by Peter Kuipers (CFO and principal financial/accounting officer) on February 26, 2026.

Why It Matters

• This filing notifies investors that Clover has publicly released its quarterly and full-year 2025 financial results; those results may affect the company’s stock price and investor perception. The Form 8-K itself does not restate results in full—investors should review the furnished press release (Exhibit 99.1) or the company’s investor relations materials for the detailed figures on revenue, earnings, guidance, or other metrics.